TPST1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.493000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.297000E-01
Normal-vs-Stage2
2.925800E-01
Normal-vs-Stage3
7.126800E-01
Normal-vs-Stage4
7.418400E-01
Stage1-vs-Stage2
5.796600E-01
Stage1-vs-Stage3
9.519000E-01
Stage1-vs-Stage4
9.788800E-01
Stage2-vs-Stage3
7.276000E-01
Stage2-vs-Stage4
6.107000E-01
Stage3-vs-Stage4
9.298000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.013000E-01
Normal-vs-AfricanAmerican
4.721800E-01
Normal-vs-Asian
1.550450E-01
Caucasian-vs-AfricanAmerican
6.278000E-01
Caucasian-vs-Asian
1.439360E-01
AfricanAmerican-vs-Asian
4.884200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.200400E-01
Normal-vs-Female
6.946400E-01
Male-vs-Female
3.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.306200E-01
Normal-vs-Age(41-60Yrs)
9.469400E-01
Normal-vs-Age(61-80Yrs)
3.149200E-01
Normal-vs-Age(81-100Yrs)
3.465400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.199400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.462800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.737380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.930130E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.908620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.904190E-01
Normal-vs-Daily Drinker
2.467400E-01
Normal-vs-Weekly Drinker
8.000200E-01
Normal-vs-Occasional Drinker
5.663200E-01
Normal-vs-Social Drinker
9.312800E-01
Non Drinker-vs-Daily Drinker
7.263200E-01
Non Drinker-vs-Weekly Drinker
1.065450E-01
Non Drinker-vs-Occasional Drinker
1.132820E-01
Non Drinker-vs-Social Drinker
1.738050E-01
Daily Drinker-vs-Weekly Drinker
1.985960E-01
Daily Drinker-vs-Occasional Drinker
2.220000E-01
Daily Drinker-vs-Social Drinker
2.214400E-01
Weekly Drinker-vs-Occasional Drinker
7.393000E-01
Weekly Drinker-vs-Social Drinker
6.324600E-01
Occasional Drinker-vs-Social Drinker
4.770000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.622000E-01
Normal-vs-Grade 2
7.775000E-01
Normal-vs-Grade 3
7.296600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.178000E-01
Grade 1-vs-Grade 3
3.174400E-01
Grade 1-vs-Grade 4
5.622000E-01
Grade 2-vs-Grade 3
1.247000E-01
Grade 2-vs-Grade 4
7.775000E-01
Grade 3-vs-Grade 4
7.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.635200E-01
Normal-vs-NonDiabetic
5.808800E-01
Diabetic-vs-NonDiabetic
6.339000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.693000E-01
Normal-vs-NoPancreatitis
6.167400E-01
Pancreatitis-vs-NoPancreatitis
5.812200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.148000E-01
Normal-vs-N1
3.369000E-01
N0-vs-N1
2.535200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.841400E-01
Normal-vs-TP53-NonMutant
7.600800E-01
TP53-Mutant-vs-TP53-NonMutant
1.024420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
